Containing Or Obtained From Echinacea (e.g., Coneflower, Etc.) Patents (Class 424/737)
-
Patent number: 7597912Abstract: As described below, the present invention provides methods and compositions for controlling a honey bee parasitic mite. In addition, the invention features compositions useful for the treatment or prevention of a parasitic mite infestation in a honey bee hive.Type: GrantFiled: April 2, 2007Date of Patent: October 6, 2009Inventor: Gene Probasco
-
Patent number: 7595067Abstract: This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The invention describes compositions for a medical foods that are designed to improve cognitive function, induced sleep, a improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as coca. The invention also describes the use of physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.Type: GrantFiled: March 5, 2007Date of Patent: September 29, 2009Assignee: Targeted Medical Pharma Inc.Inventors: William Shell, Elizabeth Charuvastra
-
Publication number: 20090191288Abstract: An improved method (process) and medicinal composition is provided to treat herpes, pseudomonas, hepatitis, staph (staphylococci) and other infectious diseases The inexpensive medicinal composition can be self-administered and maintained for a prescribed time. The attractive medicinal composition can comprise a quaternary ammonium salt surfactant, a skin protectant and an alcohol. The quaternary ammonium salt surfactant can comprise benzalkonium halide, preferably benzalkonium chloride. The skin protectant can comprise Allantoin. The alcohol can serve as a pain reliever and can comprise benzyl alcohol. The medicinal composition can also include other compounds, additives, herbal extracts and/or carriers.Type: ApplicationFiled: October 9, 2008Publication date: July 30, 2009Inventor: Meryl J. Squires
-
Publication number: 20090186104Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.Type: ApplicationFiled: April 2, 2009Publication date: July 23, 2009Applicant: Herbal Synthesis CorporationInventors: William Z. Levine, Aron J. Saffer, Mina Fran
-
Publication number: 20090186099Abstract: Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant.Type: ApplicationFiled: January 9, 2009Publication date: July 23, 2009Inventor: Harry A. Dugger, III
-
Patent number: 7563466Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.Type: GrantFiled: May 22, 2002Date of Patent: July 21, 2009Assignee: Izun Pharmaceuticals CorporationInventors: William Z. Levine, Aron J. Saffer, Mina Faran
-
Publication number: 20090175928Abstract: The invention relates to a self-adhesive lip plaster which comprises at least one single-layered matrix and which contains at least one antiviral active medical substance for using in the event of Herpes labialis. Said matrix is arranged on a flexible carrier film which is hydrophobic and also permeable to vapor.Type: ApplicationFiled: October 9, 2006Publication date: July 9, 2009Inventors: Stephan Maier, Ulrike Vollmer
-
Patent number: 7553501Abstract: Phytoceutical composition for the prevention and treatment of inmune disorders. A specific combination of extracts of plants is taught, as well as the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence and Organization.Type: GrantFiled: November 16, 2006Date of Patent: June 30, 2009Inventor: Jose Angel Olalde Rangel
-
Publication number: 20090130225Abstract: The present invention provides macrolide derivatives, which can be used as antibacterial agents. Compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram-positive, gram-negative or anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Moraxalla spp., Chlamydia spp., Mycoplasm, Legionella spp., Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Propionibeacterium, Bacillus, Enterobactericeae or any combination thereof. Also provided are processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods of treating bacterial infections.Type: ApplicationFiled: November 21, 2006Publication date: May 21, 2009Inventors: Anjan Chakrabarti, Biswajit Das, Jitendra Sambhaji Jadhav, Dilip J. Upadhyay
-
Publication number: 20090074893Abstract: The invention provides a method for the prevention or treatment of virus infections comprising administering, to a human or animal individual susceptible to or suffering from a virus infection, an effective amount of one or more casein phosphopeptides (CPP). Also provided is a composition containing such casein peptides and further agents such as vitamin C and/or nutritional components for use in treating or preventing virus infections.Type: ApplicationFiled: April 28, 2006Publication date: March 19, 2009Applicant: CAMPINA NEDERLAND HOLDING B.V.Inventors: Rick de Waard, Yves Pouliot, Christina Juneau, Leon Franciscus Mallee
-
Patent number: 7491414Abstract: An Echinacea composition containing the immunosuppressive components of an Echinacea extract but not the immunostimulatory components is disclosed. A process for isolating Echinacea immunosuppressive components by extraction with lipophilic compounds is also disclosed. The Echinacea composition can be used for treatment of colds, flu, and other upper respiratory tract infections, inflammatory diseases, and immunomodulatory disorders.Type: GrantFiled: October 12, 2005Date of Patent: February 17, 2009Assignee: Gaia Herbs, Inc.Inventor: Xiping Wang
-
Publication number: 20080254143Abstract: A composition and method for enhancing the immune system of an individual is provided. The present invention enhances the functioning of the immune system through increasing the production of certain cytokines, inhibiting viral adhesion and interfering in the viral replication process. The severity and duration of infections resulting from the common cold and associated viral infections are also reduced through the oral administration of the composition of the present invention. The composition of the present invention comprises at least an effective amount of an extract of wolfberry (Lycium barbarum), and an effective amount of an extract of elderberry. The present invention may additionally comprise effective amounts of one or more of an extract of blueberry, Echinacea root, and Vitamin C.Type: ApplicationFiled: April 10, 2007Publication date: October 16, 2008Inventors: MARVIN HEUER, KEN CLEMENT, CHAUDHURI SHAN, MEGAN THOMAS
-
Publication number: 20080166435Abstract: A composition including one or more of elecampane rhizome (Inula sp.), fennel fruit (Foeniculum sp.), juniper berry (Juniperus sp.), licorice root (Glycyrrhiza sp.), oregano herb (Oreganum sp.), marigold flowers (Calendula sp.), rose hips (Rosa sp.), and thyme (Thymus sp.), or an extract thereof. The composition is useful for treating infectious diseases, for example viral and microbial infections, and for reducing the toxic effects of chemotherapeutic agents.Type: ApplicationFiled: December 27, 2007Publication date: July 10, 2008Inventor: Volodymyr Pylypchuk
-
Patent number: 7390512Abstract: A Phytoceutical composition for the prevention and treatment of Multiple Sclerosis (MS) and symptoms is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: September 29, 2006Date of Patent: June 24, 2008Inventor: Jose Angel Olalde Rangel
-
Publication number: 20080138446Abstract: The invention relates to a herbal composition comprising extracts from Thuja, Poke, Sweet violet, Red clover, Greater celandine and Calendula; formulations containing the herbal composition; and use of the herbal composition for preventing and/or treating skin conditions and/or abnormalities.Type: ApplicationFiled: July 2, 2004Publication date: June 12, 2008Applicant: LAVENDER HILL PROJECTS PTY LTDInventor: Karina Anna Hilterman
-
Publication number: 20080124408Abstract: The present invention relates to an Echinacea formulation which includes an alkylamide fraction comprising a 2-ene alkylamide fraction and a 2,4-diene alkylamide fraction and the weight ratio of the 2-ene alkylamide fraction to the 2,4-diene alkylamide fraction is between about 1:15 to about 2:1.Type: ApplicationFiled: July 6, 2005Publication date: May 29, 2008Applicant: MEDIHERB HOLDINGS LTD.Inventors: Reg Lehmann, Kerry Bone, Kerry Penman, Anita Matthias
-
Publication number: 20080118458Abstract: Compositions, in particular, for the treatment of the hair or of the skin, comprising at least one compound which is selected from L-carnitine or L-carnitine derivatives and at least one further substance which is selected from the group formed from active ingredients obtainable from the plants of the genus Echinacea, and also taurine and derivatives thereof.Type: ApplicationFiled: January 7, 2008Publication date: May 22, 2008Inventors: Melanie GIESEN, Klaus Rudolf SCHROEDER, Dirk PETERSOHN
-
Publication number: 20080102141Abstract: Use as a means to improve fertility of a phytotherapeutic composition and method for improving and/or promoting fertility health. The phytotherapeutic composition comprising at least 6 volume % Allium Sativum extract, 17 volume % Eleutherococcus Senticosus extract, 11 volume % Juglans Regia extract, 17 volume % Echinacea Purpurea extract, 17 volume % Viola Tricolor extract, 22 volume % Uncaria Tomentosa extract, and 11 volume % Carduus Marianus extract is used to improve fertility of mammals.Type: ApplicationFiled: October 30, 2006Publication date: May 1, 2008Inventors: Maria Antoinette Brandes, Jacobus Marinus Brandes
-
Publication number: 20080095757Abstract: The field of invention relates to Vitamin C compositions, and in particular to Vitamin C compositions containing ascorbate-glucose transport enhancers. In at least one aspect, a composition is provided herein that includes ascorbate in an amount from about 0.1% by weight of actives to about 99.9% by weight of actives, and at least one ascorbate-glucose transport enhancer in an amount from about 0.01% by weight of actives to about 99.0% by weight of actives. In another aspect, a method of improving the transport of ascorbate into cells and tissues is provided that includes providing a composition comprising ascorbate and at least one ascorbate-glucose transport enhancer.Type: ApplicationFiled: October 23, 2007Publication date: April 24, 2008Inventor: NEIL LEVIN
-
Publication number: 20080020027Abstract: Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).Type: ApplicationFiled: July 20, 2007Publication date: January 24, 2008Applicant: IZUN PHARMACEUTICALS CORP.Inventors: Zvi G. Loewy, William Zev Levine, Aron J. Saffer
-
Patent number: 7288271Abstract: The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.Type: GrantFiled: July 2, 2003Date of Patent: October 30, 2007Assignee: Nutricia N.V.Inventors: Yvo Maria Franciscus Graus, Hobbe Friso Smit, Albertus Dominicus Marcellinus Erasmus Osterhaus, Robert Johan Joseph Hageman
-
Patent number: 7135198Abstract: A preparation for oral administration, in which plant material is comminuted and treated by mixing thoroughly with an extractant. After mixing, porous inorganic particles are added to the resulting suspension, thoroughly mixed with mixture and dried. The preparation provides a homogeneous distribution of the active ingredient as well as long stability and good bioavailability of the active ingredient.Type: GrantFiled: September 30, 2002Date of Patent: November 14, 2006Assignee: Bogar AGInventors: Marijkc Frater-Schroder, Georg Frater
-
Patent number: 7070814Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising: an effective amount of an extract and/or at least one bioactive fraction from Cuminum cyminum; one or more additive selected from drugs, nutrients, vitamins, nutraceuticals, herbal drugs/products, micro nutrients, antioxidants along with pharmaceutically acceptable additives/excipient, and optionally, an effective amount of piperine or extract/fraction of piper nigrum or piper longum; and a process for the preparation of such extracts and active fractions from plant Cuminum cyminum.Type: GrantFiled: March 11, 2003Date of Patent: July 4, 2006Assignee: Council of Scientific and Industrial ResearchInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chander Sharma, Sheikh Tasaduq Absullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
-
Patent number: 7037535Abstract: Methods for neutralizing dust mite feces are disclosed. In one embodiment, a botanical extract having a BAPNA-Trypsin Inhibition (IC50×10?3 (%, v/v or w/v) of from about 0.01 to about 500 and a sufficient solubility in water is introduced into water to form an aqueous botanical extract solution. The aqueous botanical extract solution is atomized into an area being treated such that the botanical extract contacts and neutralizes the dust mite feces located in the area. Particularly preferred botanical extracts for use in the botanical extract aqueous solutions of the present invention include Green Tea Extra and Grape Seed Extract.Type: GrantFiled: November 19, 2002Date of Patent: May 2, 2006Assignee: Kimberly-Clark Worldwide, Inc.Inventors: David J. Tyrrell, Duane G. Krzysik
-
Patent number: 7022350Abstract: A dietary supplement for treating or preventing prostate disease and/or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d-delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.Type: GrantFiled: April 27, 2004Date of Patent: April 4, 2006Assignee: Proethic Pharmaceuticals, Inc.Inventors: Bryce M. Harvey, Philip M. Knight
-
Patent number: 6977081Abstract: The present invention provides emollient creams composed of sulfur, sodium sulfacetamide and a botanically-derived anti-inflammatory ingredient. The creams are alcohol-free and have a pH at or above 7.0.Type: GrantFiled: December 18, 2002Date of Patent: December 20, 2005Assignee: Upsher-Smith Laboratories, Inc.Inventor: Gloria Rood
-
Patent number: 6881426Abstract: An Echinacea angustifolia extract and a process for the preparation thereof are herein described. The extract is characterized by an alkylamides content lower than 0.1%, an echinacoside content ranging from 1 to 10% and containing from 1 to 15% of a polysaccharide characteristic of Echinacea angustifolia. The extract can be used for the treatment of pathological conditions in which it is desirable to strengthen the immune defenses.Type: GrantFiled: November 25, 2002Date of Patent: April 19, 2005Assignee: Indena S.p.A.Inventors: Andrea Giori, Alessandro Anelli, Paolo Morazzoni, Francesco Di Pierro
-
Patent number: 6809079Abstract: The present invention provides a method and composition for the treatment of Female Sexual Arousal Disorder. Calcitonin gene-related peptide, a naturally occurring substance in the human body, is chemically conjugated to a hydrophobic agent thereby increasing its permeability across the skin membrane. When locally applied to female genitalia localized blood flow is promoted thus resulting in increased sexual arousal.Type: GrantFiled: January 8, 2002Date of Patent: October 26, 2004Assignee: VasoGenix Pharmaceuticals, Inc.Inventors: Jeffrey L. Southard, Gerald L. Yewey, Gary J. Rosenthal
-
Patent number: 6793941Abstract: Benzyldimethyl{2-[2-(p-1,1,3,3-tetramethylbutylphenoxy)ethoxy]ethyl} ammonium chloride (BDT) forms the basis of contact lens solutions that are unusually effective at reducing the number and wide variety of pathogenic microorganisms that may infect rigid gas permeable or soft contact lenses. Furthermore, it has been discovered that natural occurring compounds alone and in combination with chemical agents can be used in ophthalmic solutions such as contact lens solution to enhance and complement their anti-microbial, cleaning and wetting activity or to reduce irritation to the eye. The basic contact lens solution comprises an effective concentration of BDT (preferably 1 to 100 parts per million), with naturally occurring plant products possessing activities complementary to BDT, in an isotonic diluent buffered with a physiologically acceptable buffer to a physiologically natural range.Type: GrantFiled: November 13, 2000Date of Patent: September 21, 2004Assignee: Natural Disinfectant Technologies, Inc.Inventors: Chris De Bruijn, F. Richard Christ, Anthony J. Dziabo, Joseph Vigh
-
Publication number: 20040156926Abstract: The activity of the enzyme aromatase is inhibited by administering an aromatase inhibiting amount of a composition comprising at least one of astaxanthin, black cohosh, echinacea, and phytosterols to a subject.Type: ApplicationFiled: February 10, 2003Publication date: August 12, 2004Applicant: Triarco Industries, Inc.Inventor: Mark L. Anderson
-
Publication number: 20040151789Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum. Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.Type: ApplicationFiled: November 24, 2003Publication date: August 5, 2004Inventors: William Z. Levine, Aron J. Fer, Mina Faran
-
Publication number: 20040096484Abstract: Disclosed are methods products such as wet wipes and absorbents capable of providing a skin health benefit when utilized in the intended fashion. More specifically, the products described herein comprise an antioxidant agent, such as a botanical extract, which is capable of reducing the amount of oxidation on the skin's surface resulting in improved skin health. The antioxidant agent has an antioxidant potential at three minutes of at least about 25% as determined by a AST Antioxidant Status Test set forth herein. In another embodiment, the antioxidant agent has an antioxidant potential at thirty minutes of at least about 20% as determined by a AST Antioxidant Status Test set forth herein.Type: ApplicationFiled: November 19, 2002Publication date: May 20, 2004Inventors: David J. Tyrrell, Beth A. Lange, Duane G. Krzysik
-
Publication number: 20040081664Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.Type: ApplicationFiled: October 18, 2002Publication date: April 29, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Publication number: 20040071794Abstract: The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.Type: ApplicationFiled: April 8, 2003Publication date: April 15, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Publication number: 20040022878Abstract: An Echinacea angustifolia extract and a process for the preparation thereof are herein described. The extract is characterized by an alkylamides content lower than 0.1%, an echinacoside content ranging from 1 to 10% and containing from 1 to 15% of a polysaccharide characteristic of Echinacea angustifolia. The extract can be used for the treatment of pathological conditions in which it is desirable to strengthen the immune defenses.Type: ApplicationFiled: November 25, 2002Publication date: February 5, 2004Inventors: Andrea Giori, Alessandro Anelli, Paolo Morazzoni, Francesco Di Pierro
-
Publication number: 20040005344Abstract: A head lice shampoo contains adhatoda and stemona which together increase the kill rate of lice. The shampoo can be substantially free of pyrtherin.Type: ApplicationFiled: April 24, 2003Publication date: January 8, 2004Inventors: Debra Munro, John Munro, Kerry Bone
-
Publication number: 20030224064Abstract: The present invention relates to a composition for the treatment of acne comprising chlorine dioxide or chlorine dioxide generating compounds as acne reduction agents. The invention also relates to a method for treating acne by topically administering one of the compositions in an amount therapeutically effective to reduce the redness and blemishes associated with acne.Type: ApplicationFiled: April 24, 2003Publication date: December 4, 2003Inventor: William O. Kling
-
Publication number: 20030203050Abstract: A process for preparing dry extracts from a liquid extract and at least one additional substance by a spray-drying process, characterized in that said at least one additional substance is added to the spray-drying process in a dry form during the spray-drying processes.Type: ApplicationFiled: September 27, 2002Publication date: October 30, 2003Inventors: Bob Sherwood, Joseph A. Zeleznik, David Schaible, Wilhelm Berkulin, Karl-Hans Theissing
-
Publication number: 20030194435Abstract: The present invention relates to effervescent compositions containing active ingredients, in particular dry plant extracts, wherein the acid donor of the effervescent couple is constituted by a dried fruit juice with a natural acid pH, such as freeze-dried citrus fruit juice.Type: ApplicationFiled: March 31, 2003Publication date: October 16, 2003Applicant: ABOCA S.P.A.Inventor: Valentino Mercati
-
Patent number: 6632459Abstract: The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.Type: GrantFiled: December 11, 2000Date of Patent: October 14, 2003Assignee: Nutricia N.V.Inventors: Yvo Maria Franciscus Graus, Hobbe Friso Smit, Albertus Dominicus Marcellinus Erasmus Osterhaus, Robert Johan Joseph Hageman
-
Publication number: 20030185911Abstract: The present invention relates to a novel herbal nutraceutical and more particularly to novel herbal jams and jellies with proven pharmacological activities such as memory enhancer, antioxidant, anti-depressant, immuno-modulator, adapatogen, health promoter and chemically standardized on the basis of one or more bioactive constituents and also to a process for the manufacture of said herbal nutraceuticals.Type: ApplicationFiled: March 27, 2002Publication date: October 2, 2003Inventors: Gulam Nabi Qazi, Chuni Lal Tickoo, Ashok Kumar Gupta, Devinder Kumar Gupta, Bupinder Singh Jaggi, Ram Pal Singh, Gurdeep Singh, Bal Krishan Chandan, Krishan Avtar Suri, Naresh Kumar Satti, Vishwanath Gupta, Santosh Kumar Bakshi, Kasturi Lal Bedi, Om Parkash Suri, Satish Chander Puri, Preeti Somal, Surjit Singh, Anamika Khajuria, Sudesh Kumar Ganjoo, Arun Kumar
-
Publication number: 20030157185Abstract: There is provided a method for treating diseases such as fibromyalgia and diabetic neuropathy by the topical application of a composition comprising plant extracts. The composition contains a lymphatic activity or and a mobilizer of white blood cell activity and a vasodilator.Type: ApplicationFiled: February 8, 2002Publication date: August 21, 2003Inventor: Lou Paradise
-
Publication number: 20030152652Abstract: A method, wherein a composition comprising Echinacea and a pharmaceutically acceptable carrier is administered to an animal or a human, in an amount effective to cause a hematinic effect in the animal or the human. The Echinacea composition of the present invention has minimal or no side effects and is effective, simple to prepare and relatively inexpensive.Type: ApplicationFiled: November 1, 2002Publication date: August 14, 2003Inventors: John D. Baker, Wendy P. O'Neill, Andrew Clarke
-
Publication number: 20030152653Abstract: In one aspect, the present invention provides Echinacea compositions including standardized amounts of at least two Echinacea components. More preferably the Echinacea compositions of the present invention include standardized amounts of at least three Echinacea components. Presently preferred Echinacea components are cichoric acid, Echinacea alkylamides and Echinacea polysaccharides. In another aspect, the present invention provides methods for preparing Echinacea compositions, the methods including the step of combining amounts of at least two Echinacea components, preferably three Echinacea components, sufficient to yield an Echinacea composition including standardized amounts of each of the combined Echinacea components. In yet another aspect, the present invention provides Echinacea extracts, and methods for preparing Echinacea extracts. Presently preferred Echinacea extracts are enriched in one or more members of the group consisting of polysaccharides, alkylamides and cichoric acid.Type: ApplicationFiled: November 22, 2002Publication date: August 14, 2003Applicant: Factors R & D Technologies Ltd.Inventors: Roland J. Gahler, Richard E. Barton, Jan V. Slama, Chuck C. Chang
-
Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases
Publication number: 20030104082Abstract: An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the prescribed time. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent and a nutrient. In the preferred form, the medicine comprises: Echinacea and Commiphora myrrha phytochemicals, benzalkonium chloride, a sterile water solution, and folic acid.Type: ApplicationFiled: February 26, 2002Publication date: June 5, 2003Inventor: Meryl J. Squires -
Publication number: 20030099726Abstract: An improved medical treatment and medicine is provided to quickly and safely resolve herpes and other microbial infections. The inexpensive user-friendly medicine can be applied and maintained on the infected region until the physical symptoms of the disease disappears and the patient is comfortable and has a normal appearance. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent. In the preferred form, the medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution.Type: ApplicationFiled: March 7, 2002Publication date: May 29, 2003Inventor: Meryl J. Squires
-
Publication number: 20030068358Abstract: A preparation for oral administration, in which plant material is comminuted and treated by mixing thoroughly with an extractant. After mixing, porous inorganic particles are added to the resulting suspension, thoroughly mixed with mixture and dried. The preparation provides a homogeneous distribution of the active ingredient as well as long stability and good bioavailability of the active ingredient.Type: ApplicationFiled: September 30, 2002Publication date: April 10, 2003Applicant: Bogar AGInventors: Marijke Frater-Schroder, Georg Frater
-
Patent number: 6541045Abstract: An herbal composition for combating inflammation, comprising therapeutically effective amounts of Japanese knotweed, Devil's claw, grapeskin, and syzygium is provided. Also provided is an herbal composition for treating a cough and/or common cold, comprising therapeutically effective amounts of Japanese knotweed, lobelia, echinacea, slippery elm, Devil's claw, adhatoda, vitamin C, grapeskin, and syzygium. An herbal composition for alleviating menstrual discomfort, comprising therapeutically effective amounts of Japanese knotweed, chaste tree berry, Mexican wild yam, dandelion, Devil's claw, grapeskin, and syzygium is provided. Also provided is an herbal composition for soothing muscles and joints, comprising therapeutically effective amounts of Japanese knotweed, N-acetyl D-glucosamine, chondroitin sulfate, D-glucosamine hydrochloride, methylsulfonylmethane, grapeskin, syzygium, and Devil's claw. Methods of using the herbal compositions are also provided.Type: GrantFiled: January 4, 2002Date of Patent: April 1, 2003Assignee: Nutraceutical CorporationInventors: Alec Charters, James Selander, Shayne Morris, Robert Charles Thompson, Lori Blackner
-
Patent number: 6511683Abstract: In one aspect, the present invention provides Echinacea compositions including standardized amounts of at least two Echinacea components. More preferably the Echinacea compositions of the present invention include standardized amounts of at least three Echinacea components. Presently preferred Echinacea components are cichoric acid, Echinacea alkylamides and Echinacea polysaccharides. In another aspect, the present invention provides methods for preparing Echinacea compositions, the methods including the step of combining amounts of at least two Echinacea components, preferably three Echinacea components, sufficient to yield an Echinacea composition including standardized amounts of each of the combined Echinacea components. In yet another aspect, the present invention provides Echinacea extracts, and methods for preparing Echinacea extracts. Presently preferred Echinacea extracts are enriched in one or more members of the group consisting of polysaccharides, alkylamides and cichoric acid.Type: GrantFiled: September 28, 2000Date of Patent: January 28, 2003Assignee: Factors R & D Technologies Ltd.Inventors: Roland J. Gahler, Richard E. Barton, Jan V. Slama, Chuck C. Chang
-
Publication number: 20030012824Abstract: The present invention relates to an orally administered composition to relieve stress comprising from about 100 mg to about 2000 mg of at least one antacid, about 50 mg to about 500 mg of at least one anxiety reducing compound wherein the amount of anxiety reducing compound is based on a concentrated extract containing not less than 0.5% of the essential oil of the respective anxiety reducing compound, and about 20 mg to about 600 mg of at least one mental alertness inducing compound wherein the amount of the mental alertness inducing compound is based on a concentrated extract of the respective mental alertness inducing compound. The anti-stress compositions simultaneously provide the user with a considerable sense of well-being by providing relief from excess gastrointestinal acidity, reducing anxiety, and increasing mental alertness or thinking ability. The overall sense in the user is that stress is reduced emotionally as well as physically as a result of the effects of the present invention.Type: ApplicationFiled: July 3, 2001Publication date: January 16, 2003Inventors: Dana Beth Ott, Robert Henry Dobberstein